TSE:METX Stock Latest News
Company AnnouncementsME Therapeutics Extends CD22 Nanobody Licensing Option for In Vivo CAR Program2w ago
Company AnnouncementsME Therapeutics Advances Dual-Target CAR and STING mRNA Programs as NASDAQ Plans Progress1M ago
Company AnnouncementsME Therapeutics Secures Licence for CD22 Nanobody to Boost CAR Therapy Program1y ago- Company AnnouncementsME Therapeutics Secures U.S. Patent for Lead Cancer Drug Candidate1y ago
- Company AnnouncementsME Therapeutics Secures Funding to Advance mRNA Cancer Therapies1y ago
Company AnnouncementsME Therapeutics Engages Lucosky Brookman to Explore NASDAQ or NYSE Uplisting1y ago
- Company AnnouncementsME Therapeutics Expands Drug Development and Facilities2y agoMETX
- Company AnnouncementsME Therapeutics Begins Testing mRNA Cancer Treatments2y agoMETX
- Company AnnouncementsME Therapeutics Partners for mRNA Cancer Therapies2y agoMETX
- Company AnnouncementsME Therapeutics Showcases Innovations at Key Events2y agoMETX
Company AnnouncementsME Therapeutics Celebrates CSE Bell-Ringing Event2y agoMETX
- Company AnnouncementsME Therapeutics Secures $1.5M in Private Placement2y agoMETX
- Company AnnouncementsME Therapeutics Initiates $1.55M Private Placement2y agoMETX